FGF11: A Protein Regulator of Cell Biology (G2256)

Target Name: FGF11

NCBI ID: G2256

FGF11

Other Name(s): Fibroblast growth factor 11, transcript variant 1 | FLJ16061 | Fibroblast growth factor 11 (isoform 1) | FHF3 | MGC45269 | Fibroblast growth factor 11 | FGF-11 | fibroblast growth factor 11 | MGC102953 | FHF-3 | fibroblast growth factor homologous factor 3 | Fibroblast growth factor homologous factor 3 | FGF11 variant 1 | FGF11_HUMAN

FGF11: A Protein Regulator of Cell Biology

Fibroblast growth factor 11 (FGF11) is a protein that plays a critical role in cell biology, particularly in the growth and development of tissues. FGF11 is a transmembrane protein that is expressed in various tissues, including epithelial, muscle, and nervous cells. It is a potent regulator of cell proliferation, differentiation, and survival, and is involved in many physiological processes, including embryonic development, tissue repair, and regeneration.

FGF11 is a key regulator of the stem-cell maintenance and proliferation. It is known to promote the self-renewal and maintenance of stem cells, and has been shown to play a role in the development and maintenance of tissues such as skin, hair, and nails. FGF11 has also been shown to play a role in the regulation of cell plasticity, which is the ability of cells to change and adapt to their environment.

FGF11 is involved in many different signaling pathways. One of the most well-studied functions of FGF11 is its role in the regulation of cell proliferation. It has been shown to play a negative role in cell proliferation, by promoting the inhibition of the pro- growth factor, PDGF. This means that FGF11 promotes the growth and development of cells in a controlled manner, by inhibiting the uncontrolled growth that can occur with unregulated cell proliferation.

Another function of FGF11 is its role in the regulation of cell differentiation. FGF11 is known to promote the transformation of stem cells into functional tissues, such as muscles and bones. This is achieved through the regulation of the activity of several transcription factors, including MyoD8 , which is a key regulator of muscle cell differentiation.

FGF11 is also involved in the regulation of cell survival. It has been shown to play a role in the regulation of cell survival, by promoting the production of cell-cycle-specific kinases, such as p21. This means that FGF11 promotes the survival of cells by regulating their ability to divide and proliferate.

FGF11 is a potential drug target, due to its involvement in several important functions. For example, it has been shown to be a useful target for the treatment of various diseases, including cancer, wound healing, and skin regeneration. Additionally, because it is Involved in several important signaling pathways, it may be a useful target for the treatment of diseases that are caused by the misregulation of these pathways, such as neurodegenerative diseases.

In addition to its potential therapeutic applications, FGF11 is also an important biomarker for several diseases. For example, it has been shown to be elevated in various types of cancer, and may be a useful biomarker for the diagnosis and prognosis of these diseases. Additionally , FGF11 has been shown to be elevated in the brains of individuals with neurodegenerative diseases, and may be a useful biomarker for the diagnosis and prognosis of these diseases.

Overall, FGF11 is a protein that plays a critical role in several important cellular processes, including cell proliferation, differentiation, and survival. Its functions make it an attractive target for the development of new drugs, as well as a useful biomarker for the diagnosis and prognosis of various diseases. Further research is needed to fully understand the role of FGF11 in these processes, as well as its potential therapeutic applications.

Protein Name: Fibroblast Growth Factor 11

Functions: Probably involved in nervous system development and function

The "FGF11 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about FGF11 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets